Results 191 to 200 of about 193,970 (395)
ABSTRACT Background Congenital biliary dilatation (CBD) is a rare anomaly often treated surgically, yet postoperative complications remain a concern. This study aimed to evaluate the incidence, timing, and risk factors of such complications after CBD surgery.
Takuya Maeda +9 more
wiley +1 more source
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study [PDF]
Guo‐Ming Shi +22 more
openalex +1 more source
ABSTRACT Purpose There has been little discussion on the differences in characteristics and long‐term outcomes of congenital biliary dilation (CBD) by age group. Methods We conducted a regional multicenter study to investigate all pediatric cases of CBD in the Kyushu area of Japan over the past decade.
Masakazu Murakami +15 more
wiley +1 more source
Effects of intraduodenally applied bile salts on pancreatic secretion [PDF]
Lehnert, Peter, Riepl, Rudolf L.
core +1 more source
Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: A meta-analysis
Heng Liu +4 more
openalex +2 more sources
ABSTRACT Purpose To evaluate the safety and efficacy of neoadjuvant gemcitabine, cisplatin, and S‐1 (GCS) chemotherapy for resectable biliary tract cancer (BTC) and FDG‐PET‐positive lymph nodes in a multicenter phase II study (KHBO1201). Methods Patients with resectable BTC (intrahepatic/extrahepatic bile duct, gallbladder, or ampullary cancers) and ...
Satoshi Ogiso +9 more
wiley +1 more source
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [PDF]
Yuko Suzuki +11 more
openalex +1 more source
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer [PDF]
Cindy Neuzillet +19 more
openalex +1 more source
ABSTRACT We investigated the prognostic significance of the preoperative albumin‐bilirubin (ALBI) score in surgically treated head and neck squamous cell carcinoma (HNSCC). This retrospective study included 663 patients who underwent radical surgery between 2007 and 2017.
Ming‐Hsien Tsai +8 more
wiley +1 more source

